☰

Jarrod Mousa - Publications

Affiliations: 
2015-2017 Pediatrics Vanderbilt University School of Medicine, Nashville, TN, United States 
Tree Info Similar researchers PubMed Report error

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Abu-Shmais AA, Miller RJ, Janke AK, Wolters RM, Holt CM, Raju N, Carnahan RH, Crowe JE, Mousa JJ, Georgiev IS. Potent HPIV3-neutralizing IGHV5-51 Antibodies Identified from Multiple Individuals Show L Chain and CDRH3 Promiscuity. Journal of Immunology (Baltimore, Md. : 1950). PMID 38488511 DOI: 10.4049/jimmunol.2300880  0.433
2024 Gonzalez KJ, Huang J, Criado MF, Banerjee A, Tompkins SM, Mousa JJ, Strauch EM. A general computational design strategy for stabilizing viral class I fusion proteins. Nature Communications. 15: 1335. PMID 38351001 DOI: 10.1038/s41467-024-45480-z  0.343
2023 Hendy DA, Lifshits LM, Batty CJ, Carlock MA, Ross TM, Mousa JJ, Bachelder EM, Ainslie KM. Zinc Carnosine Metal-Organic Coordination Polymer as a Potent Broadly Active Influenza Vaccine Platform with In Vitro Shelf-Stability. Molecular Pharmaceutics. PMID 37603310 DOI: 10.1021/acs.molpharmaceut.3c00424  0.368
2023 Miller RJ, Mousa JJ. Structural basis for respiratory syncytial virus and human metapneumovirus neutralization. Current Opinion in Virology. 61: 101337. PMID 37544710 DOI: 10.1016/j.coviro.2023.101337  0.552
2023 Nagashima K, Mousa JJ. Epitope Binning of Monoclonal and Polyclonal Antibodies by Biolayer Interferometry. Methods in Molecular Biology (Clifton, N.J.). 2673: 17-32. PMID 37258904 DOI: 10.1007/978-1-0716-3239-0_2  0.627
2023 Dzimianski JV, Han J, Sautto GA, O'Rourke SM, Cruz JM, Pierce SR, Ecker JW, Carlock MA, Nagashima KA, Mousa JJ, Ross TM, Ward AB, DuBois RM. Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccine. Communications Biology. 6: 454. PMID 37185989 DOI: 10.1038/s42003-023-04793-3  0.482
2023 Gonzalez KJ, Huang J, Criado MF, Banerjee A, Tompkins S, Mousa JJ, Strauch EM. A general computational design strategy for stabilizing viral class I fusion proteins. Biorxiv : the Preprint Server For Biology. PMID 36993551 DOI: 10.1101/2023.03.16.532924  0.332
2023 Nagashima K, Abbadi N, Vyas V, Roegner A, Ross TM, Mousa JJ. Adjuvant-Mediated Differences in Antibody Responses to Computationally Optimized Hemagglutinin and Neuraminidase Vaccines. Viruses. 15. PMID 36851561 DOI: 10.3390/v15020347  0.483
2023 Abbadi N, Mousa JJ. Broadly Protective Neuraminidase-Based Influenza Vaccines and Monoclonal Antibodies: Target Epitopes and Mechanisms of Action. Viruses. 15. PMID 36680239 DOI: 10.3390/v15010200  0.449
2022 Durie IA, Tehrani ZR, Karaaslan E, Sorvillo TE, McGuire J, Golden JW, Welch SR, Kainulainen MH, Harmon JR, Mousa JJ, Gonzalez D, Enos S, Koksal I, Yilmaz G, Karakoc HN, et al. Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus. Nature Communications. 13: 7298. PMID 36435827 DOI: 10.1038/s41467-022-34923-0  0.5
2022 Gingerich AD, Royer F, McCormick AL, Scasny A, Vidal JE, Mousa JJ. Synergistic Protection against Secondary Pneumococcal Infection by Human Monoclonal Antibodies Targeting Distinct Epitopes. Journal of Immunology (Baltimore, Md. : 1950). PMID 36427003 DOI: 10.4049/jimmunol.2200349  0.417
2022 Cable J, Saphire EO, Hayday AC, Wiltshire TD, Mousa JJ, Humphreys DP, Breij ECW, Bruhns P, Broketa M, Furuya G, Hauser BM, Mahévas M, Carfi A, Cantaert T, Kwong PD, et al. Antibodies as drugs-a Keystone Symposia report. Annals of the New York Academy of Sciences. PMID 36382536 DOI: 10.1111/nyas.14915  0.694
2022 Gingerich AD, Royer F, McCormick AL, Scasny A, Vidal JE, Mousa JJ. Synergistic Protection against Secondary Pneumococcal Infection by Human Monoclonal Antibodies Targeting Distinct Epitopes. Journal of Immunology (Baltimore, Md. : 1950). PMID 36351696 DOI: 10.4049/jimmunol.2200349  0.42
2022 Huang J, Miller RJ, Mousa JJ. A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion protein. Frontiers in Immunology. 13: 941865. PMID 36003370 DOI: 10.3389/fimmu.2022.941865  0.578
2022 Abbadi N, Nagashima K, Pena-Briseno A, Ross TM, Mousa JJ. Differential Recognition of Computationally Optimized H3 Hemagglutinin Influenza Vaccine Candidates by Human Antibodies. Journal of Virology. e0089622. PMID 35916534 DOI: 10.1128/jvi.00896-22  0.497
2022 Beavis AC, Li Z, Briggs K, Huertas-Díaz MC, Wrobel ER, Najera M, An D, Orr-Burks N, Murray J, Patil P, Huang J, Mousa J, Hao L, Hsiang TY, Gale M, et al. Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants. Biorxiv : the Preprint Server For Biology. PMID 35702147 DOI: 10.1101/2022.06.07.495215  0.317
2022 Nagashima K, Dzimianski JV, Han J, Abbadi N, Gingerich AD, Royer F, O'Rourke S, Sautto GA, Ross TM, Ward AB, DuBois RM, Mousa JJ. The Pre-Existing Human Antibody Repertoire to Computationally Optimized Influenza H1 Hemagglutinin Vaccines. Journal of Immunology (Baltimore, Md. : 1950). PMID 35697384 DOI: 10.4049/jimmunol.2101171  0.392
2022 Banerjee A, Huang J, Rush SA, Murray J, Gingerich AD, Royer F, Hsieh CL, Tripp RA, McLellan JS, Mousa JJ. Structural basis for ultrapotent antibody-mediated neutralization of human metapneumovirus. Proceedings of the National Academy of Sciences of the United States of America. 119: e2203326119. PMID 35696580 DOI: 10.1073/pnas.2203326119  0.657
2022 Gingerich AD, Mousa JJ. Diverse Mechanisms of Protective Anti-Pneumococcal Antibodies. Frontiers in Cellular and Infection Microbiology. 12: 824788. PMID 35155281 DOI: 10.3389/fcimb.2022.824788  0.456
2021 Huang J, Chopra P, Liu L, Nagy T, Murray J, Tripp RA, Boons GJ, Mousa JJ. Structure, immunogenicity, and conformation-dependent receptor binding of the post-fusion human metapneumovirus F protein. Journal of Virology. JVI0059321. PMID 34160259 DOI: 10.1128/JVI.00593-21  0.521
2021 Ozdilek A, Huang J, Babb R, Paschall AV, Middleton DR, Duke JA, Pirofski LA, Mousa JJ, Avci FY. A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies. Mbio. e0080021. PMID 34061603 DOI: 10.1128/mBio.00800-21  0.551
2021 Nagashima KA, Mousa JJ. Next-Generation Influenza HA Immunogens and Adjuvants in Pursuit of a Broadly Protective Vaccine. Viruses. 13. PMID 33805245 DOI: 10.3390/v13040546  0.36
2021 Huang J, Gingerich AD, Royer F, Paschall AV, Pena-Briseno A, Avci FY, Mousa JJ. Broadly reactive human monoclonal antibodies targeting the pneumococcal histidine triad protein protect against fatal pneumococcal infection. Infection and Immunity. PMID 33649050 DOI: 10.1128/IAI.00747-20  0.433
2020 Dong J, Cross RW, Doyle MP, Kose N, Mousa JJ, Annand EJ, Borisevich V, Agans KN, Sutton R, Nargi R, Majedi M, Fenton KA, Reichard W, Bombardi RG, Geisbert TW, et al. Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein. Cell. 183: 1536-1550.e17. PMID 33306954 DOI: 10.1016/j.cell.2020.11.023  0.745
2020 Huang J, Diaz D, Mousa JJ. Antibody recognition of the Pneumovirus fusion protein trimer interface. Plos Pathogens. 16: e1008942. PMID 33035266 DOI: 10.1371/journal.ppat.1008942  0.543
2019 Huang J, Diaz D, Mousa JJ. Antibody Epitopes of Pneumovirus Fusion Proteins. Frontiers in Immunology. 10: 2778. PMID 31849961 DOI: 10.3389/fimmu.2019.02778  0.669
2019 Bar-Peled Y, Huang J, Nuñez IA, Pierce SR, Ecker JW, Ross TM, Mousa JJ. Structural and antigenic characterization of a computationally-optimized H5 hemagglutinin influenza vaccine. Vaccine. PMID 31481254 DOI: 10.1016/J.Vaccine.2019.08.062  0.763
2019 Bar-Peled Y, Diaz D, Pena-Briseno A, Murray J, Huang J, Tripp RA, Mousa JJ. A potent neutralizing site III-specific human antibody neutralizes human metapneumovirus . Journal of Virology. PMID 31292250 DOI: 10.1128/JVI.00342-19  0.657
2018 Mousa JJ, Binshtein E, Human S, Fong RH, Alvarado G, Doranz BJ, Moore ML, Ohi MD, Crowe JE. Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins. Plos Pathogens. 14: e1006837. PMID 29470533 DOI: 10.1371/Journal.Ppat.1006837  0.822
2017 Mousa JJ, Kose N, Matta P, Gilchuk P, Crowe JE. A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein. Nature Microbiology. 2: 16271. PMID 28134924 DOI: 10.1038/nmicrobiol.2016.271  0.652
2017 Wen X, Mousa JJ, Bates JT, Lamb RA, Crowe JE, Jardetzky TS. Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus. Nature Microbiology. 2: 16272. PMID 28134915 DOI: 10.1038/Nmicrobiol.2016.272  0.789
2016 Mousa JJ, Sauer MF, Sevy AM, Finn JA, Bates JT, Alvarado G, King HG, Loerinc LB, Fong RH, Doranz BJ, Correia BE, Kalyuzhniy O, Wen X, Jardetzky TS, Schief WR, et al. Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein. Proceedings of the National Academy of Sciences of the United States of America. PMID 27791117 DOI: 10.1073/Pnas.1609449113  0.53
2016 Wen X, Pickens J, Mousa JJ, Leser GP, Lamb RA, Crowe JE, Jardetzky TS. A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSV. Plos One. 11: e0155917. PMID 27224013 DOI: 10.1371/Journal.Pone.0155917  0.777
Show low-probability matches.